A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis: A British Society for Haematology Guideline von McMullin, Mary F F, Mead, Adam J, Ali, Sahra, Cargo, Catherine, Chen, Frederick, Ewing, Joanne, Garg, Mamta, Godfrey, Anna, Knapper, Steven, McLornan, Donal P, Nangalia, Jyoti, Sekhar, Mallika, Wadelin, Frances, Harrison, Claire N

Volltext

Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet von BARBUI, Tiziano, BAROSI, Giovanni, KILADJIAN, Jean-Jacques, KRÖGER, Nicolaus, MESA, Ruben, MCMULLIN, Mary F, PARDANANI, Animesh, PASSAMONTI, Francesco, VANNUCCHI, Alessandro M, REITER, Andreas, SILVER, Richard T, VERSTOVSEK, Srdan, BIRGEGARD, Gunnar, TEFFERI, Ayalew, CERVANTES, Francisco, FINAZZI, Guido, GRIESSHAMMER, Martin, HARRISON, Claire, HASSELBALCH, Hans Carl, HEHLMANN, Rudiger, HOFFMAN, Ronald

Volltext

Revised response criteria for polycythemia vera and essential thrombocythemia: an ELN and IWG-MRT consensus project von Barosi, Giovanni, Mesa, Ruben, Finazzi, Guido, Harrison, Claire, Kiladjian, Jean-Jacques, Lengfelder, Eva, McMullin, Mary F., Passamonti, Francesco, Vannucchi, Alessandro M., Besses, Carlos, Gisslinger, Heinz, Samuelsson, Jan, Verstovsek, Srdan, Hoffman, Ronald, Pardanani, Animesh, Cervantes, Francisco, Tefferi, Ayalew, Barbui, Tiziano

Volltext

Hereditary thrombocytosis: the genetic landscape von Han, Eun Y., Catherwood, Mark, McMullin, Mary F.

Volltext

Arsenic trioxide and all- trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial von Burnett, Alan K, Prof, Russell, Nigel H, Prof, Hills, Robert K, DPhil, Bowen, David, Prof, Kell, Jonathan, MD, Knapper, Steve, DM, Morgan, Yvonne G, PhD, Lok, Jennie, MSc, Grech, Angela, BA, Jones, Gail, MD, Khwaja, Asim, Prof, Friis, Lone, PhD, McMullin, Mary Frances, Prof, Hunter, Ann, MD, Clark, Richard E, Prof, Grimwade, David, Prof

Volltext

Molecular pathogenesis of the myeloproliferative neoplasms von Greenfield, Graeme, McMullin, Mary Frances, Mills, Ken

Volltext

Molecular diagnostics of myeloproliferative neoplasms von Langabeer, Stephen E., Andrikovics, Hajnalka, Asp, Julia, Bellosillo, Beatriz, Carillo, Serge, Haslam, Karl, Kjaer, Lasse, Lippert, Eric, Mansier, Olivier, Oppliger Leibundgut, Elisabeth, Percy, Melanie J., Porret, Naomi, Palmqvist, Lars, Schwarz, Jiri, McMullin, Mary F., Schnittger, Susanne, Pallisgaard, Niels, Hermouet, Sylvie

Volltext

Classification and Personalized Prognosis in Myeloproliferative Neoplasms von Grinfeld, Jacob, Nangalia, Jyoti, Baxter, E. Joanna, Wedge, David C, Angelopoulos, Nicos, Cantrill, Robert, Godfrey, Anna L, Papaemmanuil, Elli, Gundem, Gunes, MacLean, Cathy, Cook, Julia, O’Neil, Laura, O’Meara, Sarah, Teague, Jon W, Butler, Adam P, Massie, Charlie E, Williams, Nicholas, Nice, Francesca L, Andersen, Christen L, Hasselbalch, Hans C, Guglielmelli, Paola, McMullin, Mary F, Vannucchi, Alessandro M, Harrison, Claire N, Gerstung, Moritz, Green, Anthony R, Campbell, Peter J

Volltext

A comparison of low‐dose cytarabine and hydroxyurea with or without all‐trans retinoic acid for acute myeloid leukemia and high‐risk myelodysplastic syndrome in patients not consid... von Burnett, Alan K., Milligan, Donald, Prentice, Archie G., Goldstone, Anthony H., McMullin, Mary F., Hills, Robert K., Wheatley, Keith

Volltext

Attempts to Optimize Induction and Consolidation Treatment in Acute Myeloid Leukemia: Results of the MRC AML12 Trial von BURNETT, Alan K, HILLS, Robert K, MILLIGAN, Donald W, GOLDSTONE, Anthony H, PRENTICE, Archibald G, MCMULLIN, Mary-Frances, DUNCOMBE, Andrew, GIBSON, Brenda, WHEATLEY, Keith

Volltext

Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference von Barosi, Giovanni, Birgegard, Gunnar, Finazzi, Guido, Griesshammer, Martin, Harrison, Claire, Hasselbalch, Hans Carl, Kiladjian, Jean-Jacques, Lengfelder, Eva, McMullin, Mary Frances, Passamonti, Francesco, Reilly, John T., Vannucchi, Alessandro M., Barbui, Tiziano

Volltext

The impact of dose escalation and resistance modulation in older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome: the results of the LRF AML14 trial von Burnett, Alan K., Milligan, Donald, Goldstone, Anthony, Prentice, Archibald, McMullin, Mary‐Frances, Dennis, Michael, Sellwood, Elizabeth, Pallis, Monica, Russell, Nigel, Hills, Robert K., Wheatley, Keith

Volltext

Tamoxifen for the treatment of myeloproliferative neoplasms: A Phase II clinical trial and exploratory analysis von Fang, Zijian, Corbizi Fattori, Giuditta, McKerrell, Thomas, Boucher, Rebecca H., Jackson, Aimee, Fletcher, Rachel S., Forte, Dorian, Martin, Jose-Ezequiel, Fox, Sonia, Roberts, James, Glover, Rachel, Harris, Erica, Bridges, Hannah R., Grassi, Luigi, Rodriguez-Meira, Alba, Mead, Adam J., Knapper, Steven, Ewing, Joanne, Butt, Nauman M., Jain, Manish, Francis, Sebastian, Clark, Fiona J., Coppell, Jason, McMullin, Mary F., Wadelin, Frances, Narayanan, Srinivasan, Milojkovic, Dragana, Drummond, Mark W., Sekhar, Mallika, ElDaly, Hesham, Hirst, Judy, Paramor, Maike, Baxter, E. Joanna, Godfrey, Anna L., Harrison, Claire N., Méndez-Ferrer, Simón

Volltext

Epigenetics in myeloproliferative neoplasms von Greenfield, Graeme, McMullin, Mary Frances

Volltext

Mutational profiling in suspected triple-negative essential thrombocythaemia using targeted next-generation sequencing in a real-world cohort von Michail, Olga, McCallion, Patrick, McGimpsey, Julie, Hindley, Andrew, Greenfield, Graeme, McAllister, Roisin, Feerick, John, Arnold, Claire, Cross, Nick, Cuthbert, Robert, McMullin, Mary F, Catherwood, Mark A

Volltext

The ruxolitinib effect: understanding how molecular pathogenesis and epigenetic dysregulation impact therapeutic efficacy in myeloproliferative neoplasms von Greenfield, Graeme, McPherson, Suzanne, Mills, Ken, McMullin, Mary Frances

Volltext

Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations von Passamonti, Francesco, Elena, Chiara, Schnittger, Susanne, Skoda, Radek C., Green, Anthony R., Girodon, François, Kiladjian, Jean-Jacques, McMullin, Mary Frances, Ruggeri, Marco, Besses, Carles, Vannucchi, Alessandro M., Lippert, Eric, Gisslinger, Heinz, Rumi, Elisa, Lehmann, Thomas, Ortmann, Christina A., Pietra, Daniela, Pascutto, Cristiana, Haferlach, Torsten, Cazzola, Mario

Volltext

Clofarabine doubles the response rate in older patients with acute myeloid leukemia but does not improve survival von Burnett, Alan K., Russell, Nigel H., Hunter, Ann E., Milligan, Donald, Knapper, Steven, Wheatley, Keith, Yin, John, McMullin, Mary F., Ali, Sahra, Bowen, David, Hills, Robert K.

Volltext

The histone deacetylase inhibitor Romidepsin induces as a cascade of differential gene expression and altered histone H3K9 marks in myeloid leukaemia cells von Clarke, Kathryn, Young, Christine, Liberante, Fabio, McMullin, Mary-Frances, Thompson, Alexander, Mills, Ken

Volltext

A randomised evaluation of low‐dose Ara‐C plus pegylated recombinant arginase BCT‐100 versus low dose Ara‐C in older unfit patients with acute myeloid leukaemia: Results from the L... von Mussai, Francis, De Santo, Carmela, Cheng, Paul, Thomas, Ian F., Ariti, Cono, Upton, Laura, Scarpa, Ugo, Stavrou, Victoria, Sydenham, Mia, Burnett, Alan K., Knapper, Steven K., Mehta, Priyanka, McMullin, Mary F., Copland, Mhairi, Russell, Nigel H., Dennis, Mike

Volltext